{"id":3519,"date":"2024-08-28T11:00:29","date_gmt":"2024-08-28T11:00:29","guid":{"rendered":"https:\/\/kthholding.se\/?p=3519"},"modified":"2024-08-28T11:12:53","modified_gmt":"2024-08-28T11:12:53","slug":"new-investment-cell2bio","status":"publish","type":"post","link":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/","title":{"rendered":"New investment: Cell2Bio"},"content":{"rendered":"

[vc_section][vc_row el_class=”hero”][vc_column][vc_row_inner el_class=”same-row”][vc_column_inner][vc_column_text el_class=”back-link same-row”]<\/p>\n

\n
<\/div>\n<\/div>\n

Tillbaka<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_custom_heading source=”post_title” font_container=”tag:h1|font_size:36px|text_align:left|color:%2305101f” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:700%20bold%20regular%3A700%3Anormal”][vc_column_text el_class=”description-hero”]<\/p>\n

KTH Holding announces its investment in Cell2Bio AB \u2013 a KTH spinoff advancing the field of cell culture with its proprietary technology focused on the growth of cell spheroids. Spheroids are 3D cell structures that mimic natural cell environments such as tumors, making them crucial for drug development and biotech research. Unlike traditional 2D cultures, Cell2Bio\u2019s 3D spheroid technology facilitates a more realistic microenvironment, offering better insights into how cells behave in the human body.<\/strong><\/p>\n

 <\/p>\n

Cell2Bio was born out of a failed experiment where KTH researcher\u00a0HARISHA RAMACHANDRAIAH<\/a>\u00a0observed that cells grew into 3D spheroids on a cellulose coated surface. \u00a0This serendipity sparked a journey of several years of research at KTH together with his co-founders\u00a0Torbj\u00f6rn Pettersson<\/a>\u00a0and\u00a0Aman Russom<\/a>\u00a0to optimize the technology. After having teamed up with entrepreneur\u00a0Jan St\u00e5lemark<\/a>\u00a0as CEO, the technology is now ready to be launched on the market.<\/p>\n

The market for spheroid and 3D cell culture solutions is large and expanding, projected to reach $1.7 billion by 2024. The company\u2019s unique method allows for the growth of high-quality spheroids from lower concentrations of cells, including the possibility to cultivate patient-derived spheroids for personalized drug testing. This breakthrough has implications for improving cancer research and stem cell applications.<\/p>\n

Cell2Bio\u2019s technology utilizes a controlled deposition of nanocellulose coatings on various substrates such as microtiter plates and petri dishes. This creates an optimal surface for cell adhesion and spheroid formation without the need for high cell densities, reducing costs and increasing the feasibility of experiments with limited biological material.<\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section][vc_section][vc_row][vc_column][vc_single_image source=”featured_image” img_size=”full” el_class=”resize-image”][\/vc_column][\/vc_row][\/vc_section][vc_section][vc_row el_class=”hero”][vc_column][vc_column_text el_class=”description-hero”]<\/p>\n

\n
\n
\n
\n
\n
\n
\n

ell2Bio\u2019s business model includes sales of cell culture plates research institutions and pharmaceutical companies. The potential expansion into service offerings, where Cell2Bio could perform custom cell and drug tests, represents an additional growth avenue.<\/p>\n

\u201cWith the support from KTH Holding, we are set to accelerate our technology development and launch our first products within the biotech and pharmaceutical industries, as well as academic research,\u201d said Jan St\u00e5lemark, CEO of Cell2Bio.<\/strong><\/p>\n

 <\/p>\n

\u201cCell2Bio targets a growing market with a scalable and simple solution that addresses critical challenges in healthcare and scientific research,\u201d said Daniel Carlsson, Investment Manager of KTH Holding AB.<\/strong><\/p>\n

 <\/p>\n

\n

 <\/p>\n

About Cell2Bio<\/strong>\u00a0Cell2Bio is a biotechnology company dedicated to advancing cellular therapies and research through its innovative 3D cell culture technology. Its solutions enable more realistic and effective in-vitro models, particularly for cancer and stem cell research.\u00a0www.cell2bio.com<\/a><\/p>\n

 <\/p>\n

About KTH Holding AB<\/strong>\u00a0KTH Holding invests in early-stage start-up companies based on research or education at KTH. KTH Holding is part of the innovation ecosystem at KTH supporting commercialization via investments in companies and intellectual property rights. The aim is to make research, new ideas and knowledge from KTH generate a positive impact in society. The investment portfolio comprises more than 50 companies in many technology fields and development stages.\u00a0www.kthholding.se<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section][vc_section full_width=”stretch_row” el_class=”top-bot” css=”.vc_custom_1648030392493{background-color: #05101f !important;}” el_id=”move-down”][vc_row][vc_column][vc_custom_heading text=”Nyheter” font_container=”tag:h1|text_align:left|color:%23ffffff” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row el_class=”blog”][vc_column][vc_basic_grid post_type=”post” max_items=”4″ element_width=”3″ orderby=”rand” item=”514″ grid_id=”vc_gid:1724843148883-1eb7fec7-bf6a-10″][\/vc_column][\/vc_row][\/vc_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

The company develops coatings for cell culturing to enable 3D growth<\/p>\n","protected":false},"author":5,"featured_media":3522,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-3519","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","category-17","description-off"],"acf":[],"yoast_head":"\nNew investment: Cell2Bio - KTH Holding AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New investment: Cell2Bio - KTH Holding AB\" \/>\n<meta property=\"og:description\" content=\"The company develops coatings for cell culturing to enable 3D growth\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/\" \/>\n<meta property=\"og:site_name\" content=\"KTH Holding AB\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-28T11:00:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-28T11:12:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"885\" \/>\n\t<meta property=\"og:image:height\" content=\"643\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"daniel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@admin_cmbsu19r\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"daniel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kthholding.se\/#website\",\"url\":\"https:\/\/kthholding.se\/\",\"name\":\"KTH Holding AB\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kthholding.se\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#primaryimage\",\"url\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg\",\"contentUrl\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg\",\"width\":885,\"height\":643,\"caption\":\"ell culture plates coated with Cell2Bio technology for 3D spheroid growth\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#webpage\",\"url\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/\",\"name\":\"New investment: Cell2Bio - KTH Holding AB\",\"isPartOf\":{\"@id\":\"https:\/\/kthholding.se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#primaryimage\"},\"datePublished\":\"2024-08-28T11:00:29+00:00\",\"dateModified\":\"2024-08-28T11:12:53+00:00\",\"author\":{\"@id\":\"https:\/\/kthholding.se\/#\/schema\/person\/d12ee2a5838a2a5f4be27a9670f48ef9\"},\"breadcrumb\":{\"@id\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kthholding.se\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New investment: Cell2Bio\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kthholding.se\/#\/schema\/person\/d12ee2a5838a2a5f4be27a9670f48ef9\",\"name\":\"daniel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kthholding.se\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/88365140fc81574bba779c3b2e154901?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/88365140fc81574bba779c3b2e154901?s=96&d=mm&r=g\",\"caption\":\"daniel\"},\"sameAs\":[\"https:\/\/twitter.com\/admin_cmbsu19r\"],\"url\":\"https:\/\/kthholding.se\/en\/author\/daniel\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New investment: Cell2Bio - KTH Holding AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/","og_locale":"en_US","og_type":"article","og_title":"New investment: Cell2Bio - KTH Holding AB","og_description":"The company develops coatings for cell culturing to enable 3D growth","og_url":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/","og_site_name":"KTH Holding AB","article_published_time":"2024-08-28T11:00:29+00:00","article_modified_time":"2024-08-28T11:12:53+00:00","og_image":[{"width":885,"height":643,"url":"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg","type":"image\/jpeg"}],"author":"daniel","twitter_card":"summary_large_image","twitter_creator":"@admin_cmbsu19r","twitter_misc":{"Written by":"daniel","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/kthholding.se\/#website","url":"https:\/\/kthholding.se\/","name":"KTH Holding AB","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kthholding.se\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#primaryimage","url":"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg","contentUrl":"https:\/\/kthholding.se\/wp-content\/uploads\/2024\/08\/Plate.jpg","width":885,"height":643,"caption":"ell culture plates coated with Cell2Bio technology for 3D spheroid growth"},{"@type":"WebPage","@id":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#webpage","url":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/","name":"New investment: Cell2Bio - KTH Holding AB","isPartOf":{"@id":"https:\/\/kthholding.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#primaryimage"},"datePublished":"2024-08-28T11:00:29+00:00","dateModified":"2024-08-28T11:12:53+00:00","author":{"@id":"https:\/\/kthholding.se\/#\/schema\/person\/d12ee2a5838a2a5f4be27a9670f48ef9"},"breadcrumb":{"@id":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kthholding.se\/en\/new-investment-cell2bio\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kthholding.se\/en\/new-investment-cell2bio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kthholding.se\/en\/home\/"},{"@type":"ListItem","position":2,"name":"New investment: Cell2Bio"}]},{"@type":"Person","@id":"https:\/\/kthholding.se\/#\/schema\/person\/d12ee2a5838a2a5f4be27a9670f48ef9","name":"daniel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kthholding.se\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/88365140fc81574bba779c3b2e154901?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/88365140fc81574bba779c3b2e154901?s=96&d=mm&r=g","caption":"daniel"},"sameAs":["https:\/\/twitter.com\/admin_cmbsu19r"],"url":"https:\/\/kthholding.se\/en\/author\/daniel\/"}]}},"_links":{"self":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/posts\/3519"}],"collection":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/comments?post=3519"}],"version-history":[{"count":3,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/posts\/3519\/revisions"}],"predecessor-version":[{"id":3533,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/posts\/3519\/revisions\/3533"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media\/3522"}],"wp:attachment":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media?parent=3519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/categories?post=3519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/tags?post=3519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}